What is he best known for?
The fields of study he is best known for:
Molecular biology, Virus, Vaccinia, Oncolytic virus and Luciferase are his primary areas of study.
With his scientific publications, his incorporates both Virus and Thymidine kinase.
His Vaccinia study combines topics from a wide range of disciplines, such as Mice nude, Viral replication and Virology.
His research in Virology tackles topics such as Poxviridae which are related to areas like Bacteria and Escherichia coli.
Oncolytic virus is a primary field of his research addressed under Cancer.
He has researched Luciferase in several fields, including In vivo, Fusion protein and Green fluorescent protein.
His most cited work include:
- Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins (341 citations)
- Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins (341 citations)
- Imaging of light emission from the expression of luciferases in living cells and organisms: a review. (337 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Oncolytic virus, Virus, Vaccinia, Virology and Cancer.
His studies in Oncolytic virus integrate themes in fields like Cell culture, Viral replication and Pathology.
His Virus research incorporates elements of Immune system, Molecular biology, Combination therapy, Triple-negative breast cancer and In vivo.
In his study, which falls under the umbrella issue of Vaccinia, Genetic enhancement is strongly linked to Viral Plaque Assay.
His biological study spans a wide range of topics, including Cancer cell, Hepatocellular carcinoma and Cytotoxicity.
His Cancer study deals with Immunology intersecting with Chemotherapy.
He most often published in these fields:
- Oncolytic virus (121.77%)
- Virus (110.70%)
- Vaccinia (107.01%)
What were the highlights of his more recent work (between 2014-2021)?
- Oncolytic virus (121.77%)
- Virus (110.70%)
- Vaccinia (107.01%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Oncolytic virus, Virus, Vaccinia, Virology and Cancer research.
Aladar A. Szalay interconnects Molecular biology, Chemotherapy and Viral replication in the investigation of issues within Oncolytic virus.
His Virus research includes elements of Long-term potentiation, Apoptosis and Marker gene.
In his work, Combination immunotherapy is strongly intertwined with Oncology, which is a subfield of Vaccinia.
His Virology study incorporates themes from Cell culture, Innate immune system, Antibody and Myeloid cells.
The various areas that Aladar A. Szalay examines in his Cancer research study include Therapeutic effect, Mesenchymal stem cell, Triple-negative breast cancer and Stem cell.
Between 2014 and 2021, his most popular works were:
- Phase I Trial of Intravenous Oncolytic Vaccinia Virus (GL-ONC1) with Cisplatin and Radiotherapy in Patients with Locoregionally Advanced Head and Neck Carcinoma (47 citations)
- Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy. (21 citations)
- Humanized Mice with Subcutaneous Human Solid Tumors for Immune Response Analysis of Vaccinia Virus-Mediated Oncolysis (18 citations)
In his most recent research, the most cited papers focused on:
Aladar A. Szalay spends much of his time researching Oncolytic virus, Cancer research, Virotherapy, Virus and Cancer.
His Cancer research study integrates concerns from other disciplines, such as Mesenchymal stem cell and Stem cell.
His Virus study is concerned with Virology in general.
His Virology study combines topics in areas such as Melanin, Tyrosinase, Antibody and Reporter gene.
His research integrates issues of Angiogenesis, Surgery, Immunology and Oncology in his study of Cancer.
Aladar A. Szalay has included themes like Melphalan, Apoptosis, Targeted therapy, Melanoma and Sarcoma in his Vaccinia study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
